scholarly journals Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries

Circulation ◽  
2016 ◽  
Vol 133 (21) ◽  
pp. 2076-2085 ◽  
Author(s):  
Veronika J. Wirtz ◽  
Warren A. Kaplan ◽  
Gene F. Kwan ◽  
Richard O. Laing
2012 ◽  
Vol 17 (6) ◽  
pp. 651-676 ◽  
Author(s):  
Steven van de Vijver ◽  
Samuel Oti ◽  
Juliet Addo ◽  
Ama de Graft-Aikins ◽  
Charles Agyemang

2016 ◽  
Vol 1 (3) ◽  
pp. e000105 ◽  
Author(s):  
Mayowa Owolabi ◽  
Jaime J Miranda ◽  
Joseph Yaria ◽  
Bruce Ovbiagele

PLoS ONE ◽  
2019 ◽  
Vol 14 (2) ◽  
pp. e0212296 ◽  
Author(s):  
Temitope Ojo ◽  
Lynette Lester ◽  
Juliet Iwelunmor ◽  
Joyce Gyamfi ◽  
Chisom Obiezu-Umeh ◽  
...  

Author(s):  
Altyn Aringazina ◽  
Tleuberdi Kuandikov ◽  
Viktor Arkhipov

Cardiovascular diseases (CVD) are now the number one cause of death in low- and middle-income countries, including those in Central Asia (CA). Low- and middle- income countries (LMICs) bear a disproportionate and growing burden of CVD, which constitutes a challenge to national development. CVD account for more than 43% of cases of disability and 9.0% of cases of temporary disability in many developing countries. The high burden of CVD oftentimes results from insufficient preventive care and a lack of education about the prevention and treatment of these diseases. The rapidly growing burden of CVD and other major non-communicable diseases (NCDs) is a global public health threat, especially in Central Asia. Information on cardiovascular risk factors, including hypertension, diabetes, tobacco use, and alcohol use, is traditionally obtained from studies conducted in Europe and North America, which limits our understanding of these factors in Central Asia. In this review, we collected all published information on CVD in Central Asia from 2000 to 2015, which included the websites of the Ministries of Health, the World Health Organization, PubMed, and other published sources.This narrative review describes CVD burden, stroke incidence, and common CVD risk factors in the five post-Soviet countries of Central Asia (Kazakshstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Uzbekistan).


Author(s):  
Nwankwo Michael O. ◽  
Ogbonna Innocent O.

Cardio-protection is a sure way of averting the incidence of cardiovascular diseases (CVDs), which have been one of the most stubborn global causes of death. An estimated 17.9 million people died from CVDs in 2016, representing 31% of all global deaths. Of these deaths, 85% are due to heart attack and stroke. Over three quarters of CVDs deaths take place in low and middle-income countries. Out of the 17 million premature deaths (under the age of 70) due to non-communicable diseases in 2015, 82% are in low and middle-income countries, and 37% are caused by CVDs. The most preventive measure for cardiovascular disease is primary prevention of risk factors. Most cardiovascular diseases can be prevented by addressing behavioural risk factors such as tobacco use, unhealthy diet and obesity, physical inactivity and harmful use of alcohol using population-wide strategies. People with cardiovascular diseases or who are at high cardiovascular risk (due to the presence of one or more risk factors such as hypertension, diabetes, hyperlipidaemia or already established disease) need early detection and management using counselling and medicines, as appropriate. Sphenostylis stenocarpa (Hochst. ex. A. Rich) Harms is an orphan legume crop which its oil when administered to hypertensive albino rats, significantly (p< 0.05) lowered the atherogenic index of plasma (AIP), which is a strong marker for predicting the risk of cardiovascular disease. Hypertension was induced in rats using saturated NaCl solution. The rats were treated with the extracted oil at different concentrations. It was observed that Sphenostylis stenocarpa seed has low glycaemic index and that at varying concentrations and time significantly (p < 0.05) lowered the AIP.


Sign in / Sign up

Export Citation Format

Share Document